Skip to main content


2023 Gene Therapy CDMO Benchmarking ThumbnailManufacturing

2023 Gene Therapy CDMO Benchmarking

2023 Gene Therapy CDMO Benchmarking Industry Standard Research (ISR) takes pride in our suite of Quality Benchmarking work and this study is no exception. The inaugural Gene Therapy CDMO Benchmarking has a wealth of information, created with two goals in…

How Industry Benchmarks Can Inform CDMO Selection

Biopharmaceutical sponsor considerations when selecting a CDMO may include timelines, cost, regulatory requirements, capacity, quality, risks, and previous experience. To help sponsors better understand and prioritize development and manufacturing elements, ISR conducts four annual, manufacturing-specific benchmark studies that ask professionals…

Biologic Drug Product CDMO Benchmarking (5th Ed.)

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced drug product manufacturing.